Full name
TG-PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,1 | -0 | -0,4 | -1551,9 |
EBITDA | 1,4 | 0,3 | -0,2 | -161,1 |
Short time liabilities | 4,5 | 4,2 | 4 | -4,6 |
Equity capital | 2,6 | 2,6 | 2,2 | -16,6 |
Operating profit (EBIT) | 1,2 | 0 | -0,4 | -14 182,7 |
Assets | 7,5 | 6,9 | 6,2 | -10,7 |
Net profit (loss) | 1 | -0 | -0,4 | -1190,9 |
Cash | 2 | 2,1 | 1,4 | -33,5 |
Net income from sale | 29,1 | 28,6 | 27,9 | -2,4 |
Liabilities and provisions for liabilities | 4,9 | 4,3 | 4 | -7,2 |
Working assets | 6,6 | 6,2 | 5,8 | -7 |
Depreciation | 0,3 | 0,3 | 0,3 | -10 |
% | % | % | p.p. | |
Profitability of capital | 38,5 | -1,3 | -20 | -18,7 |
Equity capital to total assets | 34,9 | 37,3 | 34,8 | -2,5 |
Gross profit margin | 3,9 | -0,1 | -1,6 | -1,5 |
EBITDA Margin | 4,9 | 1 | -0,6 | -1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 56 | 54 | 52 | -2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane